Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: MURTY PHARMACEUTICALS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-18 to 2026-09-17
Current total value of award: $92724
Description: FY25. TO 6 - DRUG PRODUCT STABILITY STUDIES. POP 9/13/25-9/12/26.